Latest Applied genetics Stories
DNA relationship testing, primarily for paternity cases, is on the rise in the United States increasing more than 400 percent in the past two decades, according to the latest AABB (American Association of Blood Banks) Annual Report Summary for DNA Relationship Testing.
Using forensic genetics techniques, the UA's Conservation Genetics Lab is working to protect wild animals and catch the criminals in cases of wildlife crime.
FORT LEE, N.J., June 8, 2011 /PRNewswire/ -- Neurologix, Inc.
An investigation into direct-to-consumer (DTC) genetic tests found flawed and inaccurate results, with each one giving different results, and in some cases arriving at medical predictions that were no more accurate than flipping a coin.
FORT LEE, N.J., May 26, 2011 /PRNewswire/ -- Neurologix, Inc.
AMSTERDAM, May 23, 2011 /PRNewswire-FirstCall/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, announced today the results from studies exploring the role of adeno-associated viral (AAV) vectors for the efficient delivery of short and micro RNA to inhibit disease by RNA interference.
AMSTERDAM, May 19, 2011 /PRNewswire-FirstCall/ -- Amsterdam Molecular Therapeutics (Euronext Amsterdam: AMT), a leader in the field of human gene therapy, today provides its non-audited business update in compliance with the EU transparency directive.
Many gene therapy strategies designed to deliver a normal copy of a gene to cells carrying a disease-causing genetic mutation rely on a modified virus to transfer the gene product into affected tissues.
AMSTERDAM, May 10, 2011 /PRNewswire-FirstCall/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, provided today a status update on Glybera (alipogene tiparvovec), its gene therapy product under development for the treatment of lipoprotein lipase deficiency (LPLD). Following the submission of the Day 180 questions at the end of the first quarter to the European Medicines Agency (EMA) as part of Glybera's Market Authorisation Application...
Overcoming the gene silencing barrier opens doors for gene therapy. Lincoln, NE (PRWEB) April 12, 2011 NTC today announced the award of a Small Business Innovation Research (SBIR) Phase II grant award from the National Institute of General Medical Sciences.
- To say in too many words; to express verbosely.
- To express in too many words: sometimes used reflexively.
- The leading idea or a repeated phrase, as of a song or ballad; the refrain; burden.